8 Amendments of Inese VAIDERE related to 2020/2071(INI)
Amendment 45 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Aa. whereas medicine shortages are a growing public health threat with a serious impact on health care systems and public health;
Amendment 72 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas in the Member States with small markets, the medicines to treat rare diseases are often not available or available at substantially higher costs than in larger markets;
Amendment 187 #
Motion for a resolution
Recital J a (new)
Recital J a (new)
Ja. whereas a strong, innovative and competitive pharmaceutical industry in Europe is in the vital interest of the EU and its Member States;
Amendment 190 #
Motion for a resolution
Recital J b (new)
Recital J b (new)
Jb. whereas the pharmaceutical industry needs the right legal framework to do research, development and production of pharmaceuticals within the EU;
Amendment 529 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Commission to develop European health strategies on the basis of a common basket of drugs for the treatment of cancer and infections whose prices are harmonised, in a bid to counter recurrent shortages and ensure that patients have access to treatment; calls on the Commission to also examine, whether a harmonised price for those drugs may solve the problems of shortages for those life-saving drugs;
Amendment 536 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Commission to develop European health strategies on the basis of a common basket of drugs for the treatment of cancer and infections whose prices to consumers are harmonised across the Union, in a bid to counter recurrent shortages and ensure that patients have equal access to treatment;
Amendment 539 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13a. Calls on the Commission to further extend the joint procurement procedures on behalf of the Member States for medicines and medical equipment; particularly to establish joint procurement for medicines to treat rare diseases in order to ensure that these medicines are available in all Member States and at an equal price;
Amendment 664 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Calls on the Commission and the Member States to guarantee through the new "EU4Health" programme that equal access to treatment is available to all patients across the Union, particularly in case of severe illness, and that price of treatment does not play a role in access to quality care; urges Member States to show solidarity by increasing access to cross-border treatment;